EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sex-Related Differences in the Immune System Drive Differential Responses to Anti-PD-1 Immunotherapy

Sonja Cotra, Mohammad Kohandel iD, Michelle Przedborski iD

Biomolecules · 2024

DOI: 10.3390/biom14121513 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Sonja Cotra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Mathematics, University of Waterloo, Waterloo, ON N2L 3G1, Canada. Hauptthemen laut MEDLINE: Immunotherapy, Immune Checkpoint Inhibitors, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council, Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors, such as anti-PD-1 antibodies, represent a significant advancement in cancer immunotherapy, but their efficacy varies notably between individuals, influenced by complex biological systems. Recent evidence suggests that sex-related biological differences play a pivotal role in modulating these responses. This study uses a systems biology approach to examine how sex-specific differences in the immune system contribute to variability in the response to treatment. Our model extends previous frameworks by incorporating sex-specific parameters that reflect observed immunological distinctions. The results from the simulation studies align with our clinical observations, showing that on average, males exhibit a more robust response to anti-PD-1 treatment compared to females. Additionally, this study explores the potential of combination therapy with recombinant IL-12, revealing sex-specific differences in treatment efficacy. These findings underscore the need for personalized immunotherapy strategies that consider individual immunological profiles, including sex, to optimize treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyImmune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorHumansFemaleMaleNeoplasmsSex CharacteristicsInterleukin-12Immune SystemSex Factors

Stichwörter der Autor:innen

anti-PD-1 immunotherapyimmune checkpoint inhibitorspersonalized immunotherapysex-specific differencessystems biology

Substanzen

Immune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorPDCD1 protein, humanInterleukin-12

Autor:innen und Institutionen

  • Department of Applied Mathematics, University of Waterloo, Waterloo, ON N2L 3G1, Canada.

ORCID-Profile: Mohammad Kohandel, Michelle Przedborski

Förderung

  • Natural Sciences and Engineering Research Council
  • Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants Program

Zitieren

APA

Cotra, S., Kohandel, M., & Przedborski, M. (2024). Sex-Related Differences in the Immune System Drive Differential Responses to Anti-PD-1 Immunotherapy. Biomolecules. https://doi.org/10.3390/biom14121513

Vancouver

Cotra S, Kohandel M, Przedborski M. Sex-Related Differences in the Immune System Drive Differential Responses to Anti-PD-1 Immunotherapy. Biomolecules. 2024. doi:10.3390/biom14121513

BibTeX
@article{Cotra2024,
  author = {Cotra, Sonja and Kohandel, Mohammad and Przedborski, Michelle},
  title = {Sex-Related Differences in the Immune System Drive Differential Responses to Anti-PD-1 Immunotherapy},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14121513}
}
Kostenlos starten →